- Home
- FORA vs BRNS Comparison
FORA vs BRNS Comparison
Compare FORA & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORA
- BRNS
- Stock Information
- Founded
- FORA 2014
- BRNS 2016
- Country
- FORA United States
- BRNS United Kingdom
- Employees
- FORA N/A
- BRNS N/A
- Industry
- FORA Computer Software: Prepackaged Software
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- FORA Technology
- BRNS Health Care
- Exchange
- FORA Nasdaq
- BRNS Nasdaq
- Market Cap
- FORA 69.4M
- BRNS 55.9M
- IPO Year
- FORA N/A
- BRNS 2021
- Fundamental
- Price
- FORA $2.24
- BRNS $1.32
- Analyst Decision
- FORA Strong Buy
- BRNS Strong Buy
- Analyst Count
- FORA 1
- BRNS 1
- Target Price
- FORA $5.00
- BRNS $3.00
- AVG Volume (30 Days)
- FORA 389.0K
- BRNS 68.8K
- Earning Date
- FORA 11-11-2025
- BRNS 11-06-2025
- Dividend Yield
- FORA N/A
- BRNS N/A
- EPS Growth
- FORA N/A
- BRNS N/A
- EPS
- FORA N/A
- BRNS N/A
- Revenue
- FORA $25,031,040.00
- BRNS $14,969,000.00
- Revenue This Year
- FORA $47.82
- BRNS N/A
- Revenue Next Year
- FORA $10.11
- BRNS N/A
- P/E Ratio
- FORA N/A
- BRNS N/A
- Revenue Growth
- FORA 18.59
- BRNS 1766.46
- 52 Week Low
- FORA $1.64
- BRNS $0.64
- 52 Week High
- FORA $4.03
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- FORA 50.12
- BRNS 49.60
- Support Level
- FORA $2.11
- BRNS $1.20
- Resistance Level
- FORA $2.41
- BRNS $1.40
- Average True Range (ATR)
- FORA 0.13
- BRNS 0.12
- MACD
- FORA -0.00
- BRNS -0.01
- Stochastic Oscillator
- FORA 36.11
- BRNS 39.00
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.